OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects
Pratibha Sharma, Manjinder Singh
Life Sciences (2023) Vol. 320, pp. 121568-121568
Closed Access | Times Cited: 14

Showing 14 citing articles:

Protective effect of flavonoids on oxidative stress injury in Alzheimer’s disease
Kaixuan Wang, Xinmei Chen
Natural Product Research (2024), pp. 1-28
Closed Access | Times Cited: 7

Patenting perspective on Keap1 inhibitors (2019-2024)
Yue Luo, Wenlong Yang, Yuan Zhang, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access

Causal Inference-Based Feature Selection Method for Identifying Alzheimer's Disease Biomarker
Jiansong Wu, Zhao Liu, Xiaolong Zhou, et al.
Communications in computer and information science (2025), pp. 103-114
Closed Access

Dinuclear copper(II) complexes with a bridging bis(chalcone) ligand reveal considerable in vitro cytotoxicity on human cancer cells and enhanced selectivity
Zdeněk Trávnı́ček, Ján Vančo, Jan Belza, et al.
Journal of Inorganic Biochemistry (2024) Vol. 252, pp. 112481-112481
Closed Access | Times Cited: 4

N‐methylpiperazinyl and piperdinylalkyl‐O‐chalcone derivatives as potential polyfunctional agents against Alzheimer's disease: Design, synthesis and biological evaluation
Pratibha Sharma, Varinder Singh, Manjinder Singh
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 5, pp. 1155-1175
Closed Access | Times Cited: 7

Computational Studies to Understand the Neuroprotective Mechanism of Action Basil Compounds
Varinder Singh, Somdutt Mujwar, Manjinder Singh, et al.
Molecules (2023) Vol. 28, Iss. 20, pp. 7005-7005
Open Access | Times Cited: 6

Recent Development of Novel Aminoethyl-Substituted Chalcones as Potential Drug Candidates for the Treatment of Alzheimer’s Disease
Pratibha Sharma, Manjinder Singh, Varinder Singh, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6579-6579
Open Access | Times Cited: 4

Dictamnine derivatives as a novel family of dual inhibitors for cholinesterase and β-amyloid aggregation
Yongmei Zhao, Jianwu Lv, Hongli Yu, et al.
Journal of Molecular Structure (2023) Vol. 1293, pp. 136222-136222
Closed Access | Times Cited: 3

Development of novel chalcone derivatives as multifunctional agents for the treatment of Alzheimer’s disease
Xinjuan Li, Yuting Li, Zhengwei Liu, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 3, pp. 548-561
Closed Access

Cyclodextrin Complexes for the Treatment of Chagas Disease: A Literature Review
Fabrice Taio, Attílio Converti, Ádley Antonini Neves de Lima
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9511-9511
Open Access

Synthesis, characterization and in silico studies of coumarin-chalcone derivatives and their cytotoxicity activity against breast cancer cells
Muhammad Rahama, Melati Khairuddean, Noor Zafirah Ismail, et al.
Journal of Molecular Structure (2024), pp. 140341-140341
Closed Access

MAO-B Inhibitor (2E)-3-(4-Bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one as a Neuroprotective Agent Against Alzheimer’s Disease
Rani Sasidharan, Ratheesh Mohanan, Neelima Kukreti, et al.
Neurochemical Research (2023) Vol. 49, Iss. 6, pp. 1518-1528
Closed Access

Page 1

Scroll to top